Process / pipelineClinical / epidemiology
Multicenter Randomized Clinical Trial — Multi-Site RCT
A multicenter randomized clinical trial (RCT) is an experimental study in which eligible participants are randomly assigned to intervention or control arms simultaneously across two or more clinical sites. By combining the rigor of randomization with enrollment from geographically or institutionally diverse centers, this design produces large samples and externally valid effect estimates that single-center trials rarely achieve. It is the regulatory gold standard for confirmatory efficacy and safety evaluation of new treatments.
Open in MethodMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
- Senn, S. (1998). Some controversies in planning and analysing multi-centre trials. Statistics in Medicine, 17(15–16), 1753–1765. DOI: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1753::AID-SIM977>3.0.CO;2-X ↗
Related methods
Referenced by
Adaptive Phase III clinical trialMatched Randomized Clinical TrialMulticenter case seriesMulticenter Case-Control StudyMulticenter cohort studyMulticenter Diagnostic Accuracy StudyMulticenter Phase I Clinical TrialMulticenter phase II clinical trialMulticenter Phase III Clinical TrialMulticenter Phase IV StudyMulticenter Screening Test EvaluationPhase III clinical trialPragmatic randomized clinical trial